A Bright Future for Immune Checkpoint Inhibitors in Mesothelioma Treatment
A new report shows that immune checkpoint inhibitors can be a practical and rational therapeutic approach to treating mesothelioma patients.…
-
-
Adoptive Cell Therapy and Interventional Oncology in Mesothelioma
New data suggests that adoptive cell therapy is a powerful, targeted way to treat malignant pleural mesothelioma. Pleural mesothelioma is… -
Drug Combo Nivolumab plus ipilimumab Has Best Survival Rates in Relapsed Mesothelioma
Malignant pleural mesothelioma is an aggressive cancer with limited therapeutic options. Pemetrexed plus platinum is often the first treatment option… -
Understanding CAR T-Cell Therapy in Malignant Mesothelioma
One of the new therapies for mesothelioma is called antigen receptor T-cell therapy. It gives promise to malignant mesothelioma patients.… -
New Enzyme Study Highlights a Potential New Mesothelioma Treatment
Maryland researchers say an enzyme in mesothelioma tissues could be key to fighting this deadly cancer. Doctors at the University… -
Using Electric Fields to Treat Tumors: Combining Standard and Innovative Treatments
Mesothelioma is a rare cancer and standard therapies are limited. So most patients consider one or more different treatments. Different… -
Living With Mesothelioma: Coping Strategies to Find Hope
Mesothelioma is a cancer caused by exposure to asbestos. One key question remains unanswered. How do diagnosed patients experience living… -
Predicting How a Patient Will Respond to Mesothelioma Treatment
Malignant pleural mesothelioma is a rare cancer. Early diagnosis is challenging. Treatments are the first clinical option in the advanced… -
Comparing 3 Standard Treatments for Mesothelioma
There are three standard treatments for malignant pleural mesothelioma. Patients and doctors want to know which is more effective. A… -
Lower Platelet Count Linked to Longer Mesothelioma Survival
A high platelet count may not bode well for people battling malignant pleural mesothelioma. New evidence suggests that survival rates…
